COCP - MCAP CO - Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. (COCP) is developing a targeted viral therapy system, leveraging crystallography and AI to generate unique patents. The company's revenue streams rely on bringing treatments for norovirus, influenza, and COVID-19 to market. The market capitalization trend, which currently stands at 0.02, complements data regarding a deep R&D cycle focused on small molecule development and the preparation of regulatory filings.

Outsourcing production and research allows Cocrystal Pharma, Inc. (COCP) to optimize costs, which is reflected in the company's total value chart. This metric determines the overall market price of the business in cash equivalents. It is calculated by multiplying the current share price by the number of outstanding securities. An increase in this indicator suggests a positive revision of the value of intellectual assets by investors. A sharp divergence of capitalization from fundamental basics increases the probability of a deep correction.